| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ... Acta neuropathologica 123, 473-484, 2012 | 1166 | 2012 |
| Dissecting the genomic complexity underlying medulloblastoma DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ... Nature 488 (7409), 100-105, 2012 | 981 | 2012 |
| Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma A Mackay, A Burford, D Carvalho, E Izquierdo, J Fazal-Salom, KR Taylor, ... Cancer cell 32 (4), 520-537. e5, 2017 | 948 | 2017 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 882 | 2016 |
| Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ... Journal of Clinical Oncology 31 (23), 2927-2935, 2013 | 537 | 2013 |
| Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International … LM Hoffman, SEM Veldhuijzen van Zanten, N Colditz, J Baugh, B Chaney, ... Journal of clinical oncology 36 (19), 1963-1972, 2018 | 369 | 2018 |
| Next-generation personalised medicine for high-risk paediatric cancer patients–The INFORM pilot study BC Worst, CM van Tilburg, GP Balasubramanian, P Fiesel, R Witt, ... European journal of cancer 65, 91-101, 2016 | 335 | 2016 |
| Childhood cancer predisposition syndromes—a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology T Ripperger, SS Bielack, A Borkhardt, IB Brecht, B Burkhardt, ... American journal of medical genetics Part A 173 (4), 1017-1037, 2017 | 316 | 2017 |
| Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location M Karremann, GH Gielen, M Hoffmann, M Wiese, N Colditz, ... Neuro-oncology 20 (1), 123-131, 2018 | 251 | 2018 |
| Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of … AO von Bueren, K von Hoff, T Pietsch, NU Gerber, M Warmuth-Metz, ... Neuro-oncology 13 (6), 669-679, 2011 | 198 | 2011 |
| FSTL5 Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma M Remke, T Hielscher, A Korshunov, PA Northcott, S Bender, M Kool, ... Journal of Clinical Oncology 29 (29), 3852-3861, 2011 | 188 | 2011 |
| The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets CM Van Tilburg, E Pfaff, KW Pajtler, KPS Langenberg, P Fiesel, BC Jones, ... Cancer discovery 11 (11), 2764-2779, 2021 | 171 | 2021 |
| Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort T Pietsch, R Schmidt, M Remke, A Korshunov, V Hovestadt, DTW Jones, ... Acta neuropathologica 128, 137-149, 2014 | 170 | 2014 |
| Treatment of children and adolescents with metastatic medulloblastoma and prognostic relevance of clinical and biologic parameters AO von Bueren, RD Kortmann, K von Hoff, C Friedrich, M Mynarek, ... Journal of clinical oncology 34 (34), 4151-4160, 2016 | 166 | 2016 |
| Frequency, risk‐factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT … K von Hoff, B Hinkes, E Dannenmann‐Stern, AO von Bueren, ... Pediatric blood & cancer 57 (6), 978-985, 2011 | 158 | 2011 |
| Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG … GO Janssens, L Gandola, S Bolle, H Mandeville, M Ramos-Albiac, ... European journal of cancer 73, 38-47, 2017 | 155 | 2017 |
| Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91 S Rutkowski, A von Bueren, K von Hoff, W Hartmann, T Shalaby, ... Clinical cancer research 13 (9), 2651-2657, 2007 | 128 | 2007 |
| TP53 Mutation Is Frequently Associated With CTNNB1 Mutation or MYCN Amplification and Is Compatible With Long-Term Survival in Medulloblastoma E Pfaff, M Remke, D Sturm, A Benner, H Witt, T Milde, AO Von Bueren, ... Journal of clinical oncology 28 (35), 5188-5196, 2010 | 122 | 2010 |
| Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem D Grammel, M Warmuth-Metz, AO von Bueren, M Kool, T Pietsch, ... Acta neuropathologica 123, 601-614, 2012 | 111 | 2012 |
| Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study C Friedrich, AO von Bueren, K von Hoff, R Kwiecien, T Pietsch, ... European journal of cancer 49 (4), 893-903, 2013 | 110 | 2013 |
